[Studies on cardiovascular drugs. VII. Adrenergic  -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
D000433:1-Propanol / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects*; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D005663:Furans / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002082:Butylamines; D005663:Furans; D013565:Sympatholytics; D000433:1-Propanol; D011433:Propranolol; D007545:Isoproterenol; D004837:Epinephrine